BRAZILIAN WOMAN FACES 73 CANCERS AND 92 BIOPSIES IN A 28-YEAR BATTLE AGAINST RARE GENETIC CONDITION

For Hilária Mireski, a resident of Brazil, cancer has never been a single, decisive battle that comes to a definitive end. Instead, it has been a relentless presence that continually returns throughout her life. Hilária lives with Gorlin-Goltz syndrome, an extremely rare genetic disorder that exponentially increases an individual’s vulnerability to developing repeated basal cell skin cancers. Her medical journey began in 1998, when unusual spots first began appearing across her face, back, scalp, and around her eyes. What started as an initial investigation soon turned into a continuous cycle of procedures; one biopsy led to another, and then another. By July 2026, Hilária had faced 73 individual cancer diagnoses and endured 92 biopsies.

The relentless progression of the disease has dramatically altered her physical appearance. In 2019, severe tumor involvement forced medical professionals to remove her left eye and part of her nose. The physical and emotional weight of these procedures was overwhelming, leading Hilária to speak openly about her ongoing struggles with severe anxiety and panic attacks following the surgery. Beyond the physical toll, the long-term treatment has created a daunting financial burden.

Essential specialized medications can cost tens of thousands of Brazilian reais, alongside substantial monthly expenses for supportive care. To cope, Hilária turned to social media, hosting livestreams and creating videos to generate necessary income and raise public awareness about Gorlin-Goltz syndrome. Despite three decades of intense hardship, she continues to hold onto simple dreams—such as reconstructive surgery for her nose and owning a home with her husband—demonstrating extraordinary resilience in the face of ongoing adversity.